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Amyris was founded over a decade ago on the premise that synthetic biology could help address some of the 
world’s most pressing challenges.  Focusing on supply-limited molecules of societal and economic value such 
as medicines, nutrients, and commodity & specialty chemicals, Amyris has enabled their cost-effective and 
sustainable production by building a high-throughput genetic engineering platform coupled to industrial scale 
fermentation processes. Until 2015 this platform primarily aimed to replace the “hands” in the lab, using 
automation & computing to perform routine calculations and liquid manipulations for the reproducible 
construction of engineered microbes.  Since then we have focused on replacing the “head” in the lab by 
implementing a suite of computational algorithms to design metabolic pathways, direct their synthesis and 
phenotyping, learn from the data, and iterate on the design for improved target molecule production.  In this 
presentation I will describe our progress on joining the hands to the head by attempting to create discrete strains 
that produce 450 novel molecules in 24 months.  This effort involved first creating an expert system that 
successfully directed the creation of >110,000 in silico strain designs, identification of >14,000 metabolic routes, 
ordering of >2,400 genes, assembly of >280 million bps of DNA, and generation of >32,000 distinct strains.  We 
are now collecting >400,000 data points each week, measurements that are fed back into proprietary machine 
learning and optimization algorithms to drive strain re-design. 
 
